Description
Elsevier Braunwalds Heart Disease International Edition 12th Edition 2021 by Peter Libby & Robert O. Bonow & Douglas L. Mann & Gordon F. Tomaselli & Deepak Bhatt & Scott D. Solomon & Eugene Braunwald
Current, comprehensive, and evidence-based, Braunwald’s Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.
Key Features
Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine.
Includes 60 new contributing authors and 12 new chapters that cover Artificial intelligence in Cardiovascular Medicine; Influenza, Pandemics, COVID-19, and Cardiovascular Disease; Tobacco and Nicotine Products in Cardiovascular Disease; Impact of Healthcare Policy on Quality, Outcomes, and Equity in Cardiovascular Disease; Impact of the Environment on Cardiovascular Health, and more.
Features a new introductory chapter, Cardiovascular Disease: Past, Present, and Future by Eugene Braunwald, MD, offering his unique, visionary approach to the field of cardiology. Dr. Braunwald also curates the extensive, bimonthly online updates that include "Hot Off the Press," "Practice Updates," and "Late-Breaking Clinical Trials."
Provides cutting-edge coverage of key topics such as proteomics and metabolomics, TAVR, diabetocardiology, and cardio-oncology.
Contains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 265 helpful videos with identifying cons.
Highlights the latest AHA and ACC guidelines to clearly summarize diagnostic criteria and clinical implications.
Provides tightly edited, focused content for quick, dependable reference. Flexible format options include either one or two volumes in print, as well as a searchable eBook with ongoing updates.
Author Information
By Peter Libby, MD, PhD, Senior Advisor, Center for Interdisciplinary Cardiovascular Sciences, Mallinckrodt Professor of Medicine, Harvard Medical School, Senior Physician, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts; Robert O. Bonow, MD, MS, Goldberg Distinguished Professor of Cardiology, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois; Douglas L. Mann, MD, Lewin Chair and Professor of Medicine and Professor of Cell Biology and Physiology at Washington University in St Louis, Missouri; Gordon F. Tomaselli, MD, Executive Vice President; Chief Academic Officer; Dean Montefiore Medicine; Professor, Department of Medicine Einstein College of Medicine, Yeshiva University, Bronx, New York; Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts ; Scott D. Solomon, MD, The Edward D. Frohlich Distinguished Chair, Professor of Medicine, Harvard Medical School, Senior Physician, Brigham and Women’s Hospital, Boston, Massachusetts. and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP, Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital,Boston, Massachusetts